Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors

Authors:

Abstract
No abstract available
Funding Information
  • Österreichische Forschungsförderungsgesellschaft

This publication has 30 references indexed in Scilit: